Answers are grounded in this paper and cite their sources.
Objective: To compare the frequency of fits in the eclamptic patients before andafter use of magnesium sulphate as anticonvulsant and enlist the complications of MgSo4.Subjects & methods: All the patients with more than 20 weeks, of gestational age, with any paritywere includes in the study. Patients developed fits before giving magnesium sulphate and afterwere evaluated, all the patients were monitored for occurrence of complications due to drug.Magnesium sulphate administered for 24 hours after last fit of delivery and patient’s bloodpressure, pulse, respiratory rate tendon reflexes and urine output was monitored half hourly.Results: Mostly fits were noted in the patients before the treatment of magnesium sulphate and 1to 3 fits were noted in the 57.1% of the cases, 28.5% patients were seen with 4 to 6 numbers of thefits while more than 6 fits were noted in the 14.2% of the cases, and after the treatment (use ofmagnesium sulphate) 1 to 3 fits were seen in the 5.7% of the cases, 4 to 6 fits were only in the 2.8%of the cases while no any patient was noted with above 6 fits. Proteinuria was present in the 80% ofthe cases and edema was found in the 42% of the patients Conclusions: In the conclusion of ourstudy MgSO4 found to be very effective and cheap for control of fits and has lower risk of recurrentconvulsion.
No takes yet. Share an insight, caveat, or question.
Kadri et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: